Melania Capasso
Immunregulation
Dr. Melania Capasso
Gruppenleiterin
Venusberg-Campus 1, Gebäude 99
(ehemals Sigmund-Freud-Str. 27)
53127 Bonn

melania.capasso@dzne.de
 +49 228 43302325

Forschungsschwerpunkte

My group is interested in elucidating pathways regulating immune cell function and how their alterations affect ageing and neurodegenerative diseases. In particular, we are interested in understanding the function of the voltage-gated proton channel HVCN1 in immune responses, as well as signalling pathways that regulate inflammation in microglia (summary in Fig. 1).

The voltage-gated proton channel HVCN1 in immune responses

There is only one mammalian voltage-gated proton channel, HVCN1. It works to relieve intracellular acidification and membrane depolarization, letting protons out of the cell following their chemical gradient. In doing so, it sustains the production of reactive oxygen species (ROS) by the enzyme NADPH oxidase (Fig. 2). We were the first to describe HVCN1 role in regulating B cell responses (Capasso et al, Nat Immunol, 2010). HVCN1 loss causes a strong impairment of antibody responses, due to reduced B Cell Receptor signaling. This is due to diminished ROS production by the NADPH oxidase: fewer ROS mean they are no longer able to oxidase and therefore inhibit phosphatases involved in B Cell Receptor signalling. We also described a splicing variant of HVCN1, shorter at the N-terminus, which is able to mediate larger currents and it is upregulated in circulating B cell malignancies such as Chronic Lymphocytic Leukaemia (Hondares et al., PNAS, 2014). Nonetheless, proton channels in B cell malignancies appear to play multiple roles, as we describe in a manuscript in preparation. In myeloid cells, HVCN1 also sustains NADPH oxidase activity, however, its role in cells implicated in the pathogenesis of Alzheimer’s disease, such as microglia and neutrophils, remains to be elucidated. We combine in vivo and in vitro studies to elucidate the impact of HVCN1 loss on this devastating neurodegenerative disease, in order to assess its potential as a therapeutic target.

 mehr dazu

Signaling pathways altered in ageing

Since ageing is the greatest risk factor for the development of neurodegenerative diseases, we study signalling pathways altered in ageing in immune cells and their impact on neurodegeneration. Aged microglia, the immune cells of the brain, are characterized by an increased ability to respond to inflammatory stimuli, a process known as microglia priming. We have established that alterations in the mTOR pathway occur with age and this is partly responsible for microglia priming (Fig. 3).

Schlüsselpublikationen

Spear S, Candido JB, McDermott JR, Ghirelli C, Maniati E, Beers SA, Balkwill FR, Kocher HM, Capasso M. Discrepancies in the Tumor Microenvironment of Spontaneous and Orthotopic Murine Models of Pancreatic Cancer Uncover a New Immunostimulatory Phenotype for B Cells. Front Immunol. 2019 Mar 27; 10:542. doi: 10.3389/fimmu.2019.00542
Gabandé-Rodríguez E, Keane L, Capasso M. Microglial phagocytosis in aging and Alzheimer's disease. J Neurosci Res. 2019 Apr 03; doi: 10.1002/jnr.24419
Hondares E, Brown MA, Musset B, Morgan D, Cherny VV,…, Capasso M. Enhanced activation of an amino-terminally truncated isoform of the voltage-gated proton channel HVCN1 enriched in malignant B cells. Proc Natl Acad Sci U S A. 2014 Jan 01; 111:18078-83. doi: 10.1073/pnas.1411390111
Capasso M, Bhamrah MK, Henley T, Boyd RS, Langlais C, Cain K, et al. HVCN1 modulates BCR signal strength via regulation of BCR-dependent generation of reactive oxygen species. Nat Immunol. 2010 Jan 01; 11:265-72. doi: 10.1038/ni.1843
Morgan D, Capasso M, Musset B, Cherny VV, Ríos E, Dyer MJ, et al. Voltage-gated proton channels maintain pH in human neutrophils during phagocytosis. Proc Natl Acad Sci U S A. 2009 Jan 01; 106:18022-7. doi: 10.1073/pnas.0905565106

Info-Hotline

Donnerstags 13.30-16.30 Uhr

Für Patienten 0800-7799001

(kostenlos)

Für Ärzte 01803-779900

(9 Cent/Min. dt. Festnetz, mobil evtl. teurer)

Informieren Sie sich bei uns Cookie-frei. Wir würden uns jedoch freuen, wenn Sie statistische Cookies zulassen würden. Ihr Browser erlaubt das setzen von Cookies:
Mehr dazu finden Sie in unserer Datenschutzerklärung.